Literature DB >> 17682348

Guidelines for management of high-risk African Americans with multiple cardiovascular risk factors: recommendations of an expert consensus panel.

Richard Allen Williams1, John M Flack, James R Gavin, Wendy R Schneider, Charles H Hennekens.   

Abstract

African Americans have higher rates of cardiovascular disease (CVD) than do Caucasians, which contributes significantly to their reduced life expectancy. Most African American adults have at least one major risk factor for CVD. Nonetheless, African Americans are often underdiagnosed and undertreated, despite presenting to the healthcare system late in their course, often after a CVD event. Patients with multiple risk factors have a CVD risk far greater than the sum of their individual risks. Metabolic syndrome tends to be clustered to a greater degree in African American women. Aggressive management of African Americans is necessary. In this report, we provide guidelines for the management of high-risk African Americans. For each individual risk factor, we address existing data and guidelines in the general population, existing data in African Americans, and proposed guidelines for African Americans based on evidence or extrapolation. In particular, for elevated cholesterol and blood pressure, evidence is emerging that lower is better, so aggressive management strategies are necessary. For dyslipidemia, statins alone will generally reach the goal, but for hypertension, multiple drugs are usually necessary. We conclude that further research in African Americans is necessary to complete the totality of evidence.

Entities:  

Mesh:

Year:  2007        PMID: 17682348

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   1.847


  5 in total

Review 1.  Evolution of Blood Pressure Clinical Practice Guidelines: A Personal Perspective.

Authors:  Paul K Whelton
Journal:  Can J Cardiol       Date:  2019-02-27       Impact factor: 5.223

Review 2.  Managing mixed dyslipidemia in special populations.

Authors:  Michael Miller
Journal:  Prev Cardiol       Date:  2010

3.  Identification of modifiable chronic kidney disease risk factors by gender in an African-American metabolic syndrome cohort.

Authors:  Loretta Jackson Brown; Patricia C Clark; Karen A Armstrong; Zhao Liping; Sandra B Dunbar
Journal:  Nephrol Nurs J       Date:  2010 Mar-Apr       Impact factor: 0.959

4.  Amlodipine/Atorvastatin single-pill therapy for blood pressure and lipid goals in African Americans: influence of the metabolic syndrome and type 2 diabetes mellitus.

Authors:  Keith C Ferdinand; John M Flack; Elijah Saunders; Ronald Victor; Karol Watson; Attila Kursun; Michael J Jamieson; Harry Shi
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-10       Impact factor: 3.738

5.  Hypertension in african americans aged 60 to 79 years: statement from the international society of hypertension in blacks.

Authors:  Brent M Egan; Veita J Bland; Angela L Brown; Keith C Ferdinand; German T Hernandez; Kenneth A Jamerson; Wallace R Johnson; David S Kountz; Jiexiang Li; Kwame Osei; James W Reed; Elijah Saunders
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-03-10       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.